tiprankstipranks
Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS
Holding PIRS?
Track your performance easily

Pieris Pharmaceuticals (PIRS) Financial Statements

593 Followers

Pieris Pharmaceuticals Financial Overview

Pieris Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-12.611; its P/E ratio is -1.24; Pieris Pharmaceuticals is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue--$ 53.00K$ 19.52M$ 20.05M
Gross Profit--$ 53.00K$ 19.52M$ 20.05M
EBIT$ -2.89M$ -3.59M$ -4.89M$ 3.09M$ 3.98M
EBITDA$ -2.89M$ -3.59M$ -4.89M$ 3.79M$ 3.98M
Net Income Common Stockholders$ -2.89M$ -3.59M$ -4.89M$ -10.75M$ 3.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.36M$ 19.73M$ 19.08M$ 44.81M$ 54.88M
Total Assets$ 20.52M$ 25.05M$ 29.50M$ 59.38M$ 87.54M
Total Debt$ 0.00$ 0.00$ 0.00$ 12.29M$ 11.92M
Net Debt$ -19.36M$ -19.73M$ -19.08M$ -32.52M$ -42.96M
Total Liabilities$ 4.25M$ 6.35M$ 7.53M$ 28.87M$ 47.05M
Stockholders Equity$ 16.27M$ 18.70M$ 21.96M$ 30.51M$ 40.50M
Cash Flow-
Free Cash Flow$ 288.00K$ 696.00K$ -7.00M$ -9.79M$ -13.50M
Operating Cash Flow$ 146.00K$ -1.48M$ -7.00M$ -9.72M$ -13.43M
Investing Cash Flow$ 142.00K$ 2.18M$ 9.00M$ -1.98M$ -1.37M
Financing Cash Flow----$ 19.78M
Currency in USD

Pieris Pharmaceuticals Earnings and Revenue History

Pieris Pharmaceuticals Debt to Assets

Pieris Pharmaceuticals Cash Flow

Pieris Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis